ICCM ▲ +11.2% - IceCure Medical Ltd
$ICCM - IceCure Enrolls First Patients in Its FDA-Approved Study for ProSense® Breast Cancer Cryoablation at Two U.S. Sites
20-OCT-2026 07:55 AM ET
Share this post
More filings for $ICCM
ICCM ▲ +4.6% - IceCure Medical LtdOct 6, 2026ICCM ▲ +2.4% - IceCure Medical LtdSep 10, 2026ICCM - IceCure Medical Ltd - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026
View full $ICCM filing history →💬 Comments
Loading comments…
Leave a comment
